• Avandia®
• Avandia® Death Risk
• Avandia® Heart Attack
• Avandia® Pph
• Congestive Heart Failure
• Dangers of Avandia®
• Avandia® Diabetes
• Avandia® Recall
• Avandia® Side Effects
• Avandia® Information
• Avandia® Attorneys
• Avandia® Lawyers
• Avandia® Lawsuit
• Avandia® Class Action Lawsuits
• Avandia® Litigations
• Avandia® Settlements
• Avandia® Overdose
• Avandia® & Weight Loss
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

The diabetes drug Avandia® has been the subject of much scrutiny over its safety, but it wasn't until a report published by the New England Journal of Medicine in May 2007 that the drug's heart risks really came to the surface. According to the NEJM report and a subsequent FDA safety alert, Avandia® may significantly raise the risk of heart attack and heart-related death in patients using the drug. Patients with a history of congestive heart failure or other heart problems face an exceptional risk of suffering an Avandia®-related cardiovascular event and are thus encouraged to consult with a physician to discuss alternative treatment options.

If you've suffered serious harm as a result of taking Avandia®, you should contact an attorney to learn more about your eligibility to seek compensation for your losses.

About Avandia®

The FDA approved Avandia® (rosiglitazone maleate) in 1992 to treat Type 2 diabetes, a prevalent condition that affects roughly 20 million Americans. Avandia® is one of GlaxoSmithKline's top-selling drugs and has been prescribed to approximately 10 million Americans since being approved.

Avandia®, however, is not without serious risks, which include:

• Liver toxicity
• Congestive heart failure and related heart complications such as edema and fluid retention
• Low blood pressure

The NEJM report shed light on yet another serious risk—potentially fatal heart attack. That report—which was based on an meta-analysis of 44 studies involving over 28,000 patients—revealed the risk of heart attack or heart-related death to be between 30 to 40 percent higher in patients taking Avandia® than those taking a placebo or other diabetes drug. The FDA, as of May 2007, said it would continue its analysis of the drug to confirm the extent of the risk.

Injured by Avandia®? Protect Your Legal Rights

One expert estimates that thousands of patients who have taken Avandia® have suffered heart-related problems, and some even death. If you are among the many Avandia® users who have suffered harm as a consequence of its use, ensure your legal rights are fully protected by contacting an attorney experienced in pharmaceutical litigation. You may be eligible to hold Glaxo responsible for your damages with an Avandia® lawsuit. Contact our Avandia® Lawyer today to learn more.

"FDA Announces Avandia® Label Change"

The FDA announced that is has made a change regarding cardiovascular risks to the Avandia® (rosiglitazone) label and patient Medication Guide, Feb. 4, 2011.

The FDA announcement also said that Avandia®'s drug label was updated ...

» Read More

"Risk of Death Halts Government Study"

A government run diabetes trial was halted 18 months early after a safety analysis revealed an increased risk of death in patients whose blood sugar levels dipped too low.

The 10,000 patient trial was examining the effectiveness of aggressive ...

» Read More

"Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avan"

A new study published in the Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avandia—that is, it carries a significantly increased risk of heart failure, heart attack, and death.

Ob...

» Read More